Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Stramer

Showing results (191-200 of 258) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|September 23, 2003
Transmission of West Nile virus through blood transfusion in the United States in 2002Lisa N Pealer, Anthony A Marfin, Lyle R Petersen, et al.
Plos Neglected Tropical Diseases|February 13, 2016
Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto RicoGermán Añez, Daniel A R Heisey, Caren Chancey, et al.
Transfusion|May 5, 2025
Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donationRenata Buccheri, Barbee Whitaker, Lance M Pollack, et al.
Transfusion|September 26, 2003
Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screeningLeslie H Tobler, Susan L Stramer, Stephen R Lee, et al.
Transfusion|December 31, 2019
Transcription-mediated amplification blood donation screening for BabesiaLaura Tonnetti, Carolyn Young, Debra A Kessler, et al.
Transfusion|August 2, 2020
Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reductionJoy L Fridey, Susan L Stramer, Ashok Nambiar, et al.
Transfusion|April 16, 2016
Two human immunodeficiency virus Type 2 cases in US blood donors including serologic, molecular, and genomic characterization of an epidemiologically unusual caseSusan L Stramer, Guixia Yu, Ross Herron, et al.
Science (New York, N.Y.)|April 1, 2017
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunitySusana V Bardina, Paul Bunduc, Shashank Tripathi, et al.
Plos Pathogens|February 28, 2009
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in manJean K Lim, Andrea Lisco, David H McDermott, et al.
Transfusion|June 21, 2022
Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reductionSusan L Stramer, Marion C Lanteri, Jaye P Brodsky, et al.
Pageof 26

Showing results (191-200 of 258) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|September 23, 2003
Transmission of West Nile virus through blood transfusion in the United States in 2002Lisa N Pealer, Anthony A Marfin, Lyle R Petersen, et al.
Plos Neglected Tropical Diseases|February 13, 2016
Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto RicoGermán Añez, Daniel A R Heisey, Caren Chancey, et al.
Transfusion|May 5, 2025
Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donationRenata Buccheri, Barbee Whitaker, Lance M Pollack, et al.
Transfusion|September 26, 2003
Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screeningLeslie H Tobler, Susan L Stramer, Stephen R Lee, et al.
Transfusion|December 31, 2019
Transcription-mediated amplification blood donation screening for BabesiaLaura Tonnetti, Carolyn Young, Debra A Kessler, et al.
Transfusion|August 2, 2020
Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reductionJoy L Fridey, Susan L Stramer, Ashok Nambiar, et al.
Transfusion|April 16, 2016
Two human immunodeficiency virus Type 2 cases in US blood donors including serologic, molecular, and genomic characterization of an epidemiologically unusual caseSusan L Stramer, Guixia Yu, Ross Herron, et al.
Science (New York, N.Y.)|April 1, 2017
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunitySusana V Bardina, Paul Bunduc, Shashank Tripathi, et al.
Plos Pathogens|February 28, 2009
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in manJean K Lim, Andrea Lisco, David H McDermott, et al.
Transfusion|June 21, 2022
Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reductionSusan L Stramer, Marion C Lanteri, Jaye P Brodsky, et al.
Pageof 26